Bentham Science Logo

Track Your Manuscript:


Current Drug Research Reviews

Formerly: Current Drug Abuse Reviews

Volume 12, 2 Issues, 2020
ISSN: 2589-9783 (Online)
ISSN: 2589-9775 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Aims & Scope

Current Drug Research Reviews publishes research articles, full-length/mini review articles and clinical studies on the design and development of new drugs, including drug targeting, medicinal chemistry, in-silico drug design, combinatorial chemistry, meta-analyses, drug abuse and addiction, drug-drug interactions and enzyme kinetics; species scaling and extrapolations; drug transporters; target organ toxicity and inter-individual variability in drug exposure-response; extrahepatic metabolism; bio-activation, reactive metabolites, high-throughput screening, drug targets and structure-activity relationships.

The journal aims to cover the latest developments in all important aspects of drug design, delivery, development and research.

Current Drug Research Reviews is essential for all pharmaceutical scientists involved in drug design and development.

Author Guidelines


Editor-in-Chief

Ricardo J. Dinis-Oliveira
University of Porto
Porto
(Portugal)

Biography View Full Editorial Board

Journal History

Current Drug Abuse Reviews was launched in 2008 and later renamed in 2018 as Current Drug Research Reviews.
Scopus CiteScore Metrics: 2.56

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog